ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 150014 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 150014; 2) Community: the network communities that were significantly associated with the response to NSC 150014; 3) Molecule: the relationships between components within communities and NSC 150014; 4) MDR: the compounds that were significantly associated with the NSC 150014.

NSC Compound Enrichment Correlation
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0480633950058475 0.53062296
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.0480633950058475 0.21654269
NSC 715407 Null 0.0480633950058475 0.41092002
NSC 718564 Null 0.0480633950058475 0.090870102
NSC 718781 Erlotinib hydrochloride 0.0480633950058475 -0.24948142
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0480633950058475 0.024780514
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0480633950058475 0.44831707
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0480633950058475 0.48863525
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0480633950058475 0.24181519
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0480633950058475 0.46556703
Total:116  Current:113    [First] [Prev] [Next] [Last]